Exicure (XCUR) Other financing activities (2018 - 2022)
Exicure (XCUR) reported Other financing activities of $506000.0 for Q1 2022, up 216.25% quarter-over-quarter from $160000.0 in Q4 2020.
Exicure (XCUR) Other financing activities (2018 - 2022) Analysis & Trends
Exicure has reported Other financing activities for 4 years, with the latest figure at $506000.0 in Q1 2022.
- For the quarter ending Q1 2022, Other financing activities changed N/A year-over-year to $506000.0; the trailing twelve-month figure through Dec 2022 stood at $506000.0 (changed N/A YoY), and the FY2022 full-year result was $506000.0, changed N/A from the prior year.
- Other financing activities for Q1 2022 stood at $506000.0, up from $160000.0 in the prior quarter.
- The five-year high for Other financing activities was $506000.0 in Q1 2022, with the low at -$1000.0 in Q4 2019.
- Historically, Other financing activities has averaged $164875.0 across 4 years, with a median of $130000.0 in 2020.
- Annual changes were most pronounced in 2019 — Other financing activities slumped 103.85% — and 2020, when it jumped 16100.0%.
- Exicure's Other financing activities stood at $26000.0 in 2018, then slumped by 103.85% to -$1000.0 in 2019, then jumped by 16100.0% to $160000.0 in 2020, then surged by 216.25% to $506000.0 in 2022.
- The last three Other financing activities figures came in at $506000.0 (Q1 2022), $160000.0 (Q4 2020), and $244000.0 (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 506,000.00 |
| Mar 31, 2022 | 506,000.00 |
| Dec 31, 2020 | 160,000.00 |
| Dec 31, 2020 | 160,000.00 |
| Sep 30, 2020 | 244,000.00 |
| Sep 30, 2020 | 244,000.00 |
| Mar 31, 2020 | 100,000.00 |
| Mar 31, 2020 | 100,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | 232,000.00 |
| Sep 30, 2019 | 232,000.00 |
| Mar 31, 2019 | 52,000.00 |
| Mar 31, 2019 | 52,000.00 |
| Dec 31, 2018 | 26,000.00 |
| Dec 31, 2018 | 26,000.00 |